Brentuximab vedotin in patients with relapsed HIV-related lymphoma.
J Natl Compr Canc Netw
; 12(1): 16-9; quiz 19, 2014 Jan.
Article
in En
| MEDLINE
| ID: mdl-24453289
ABSTRACT
Lymphoma is a well-recognized complication in patients infected with HIV. Although its incidence has declined since the advent of antiretroviral therapy, it remains higher than seen in the general population. Several recent studies have noted improvement in clinical outcomes with the use of modern chemoimmunotherapy regimens. In patients who experience relapse, however, fewer data are available on the role of immunotherapy and its impact on outcomes. This case report presents 2 patients with relapsed HIV-associated lymphoma who experienced a second complete remission after treatment with the immunotherapy agent brentuximab vedotin.
Search on Google
Database:
MEDLINE
Main subject:
Hodgkin Disease
/
HIV Infections
/
Lymphoma, AIDS-Related
/
Immunoconjugates
Limits:
Adult
/
Humans
/
Male
Language:
En
Year:
2014
Type:
Article